|
Related Articles |
Does the efficacy of parent-child training depend on maternal symptom improvement? Results from a randomized controlled trial on children and mothers both affected by attention-deficit/hyperactivity disorder (ADHD).
Eur Child Adolesc Psychiatry. 2018 Jan 23;:
Authors: Häge A, Alm B, Banaschewski T, Becker K, Colla M, Freitag C, Geissler J, von Gontard A, Graf E, Haack-Dees B, Hänig S, Hennighausen K, Hohmann S, Jacob C, Jaite C, Jennen-Steinmetz C, Kappel V, Matthies S, Philipsen A, Poustka L, Retz W, Rösler M, Schneider-Momm K, Sobanski E, Vloet TD, Warnke A, Jans T
Abstract
Multimodal treatment of children with ADHD often includes parent-child training (PCT). However, due to the high heritability, parents of children with ADHD are frequently also affected by the disorder, which is likely to constitute a significant barrier to successful treatment of the child. This secondary analysis of our randomized controlled multicentre AIMAC trial (ADHD in mothers and children) investigates whether children’s outcomes following parent-child training in combination with maternal ADHD treatment depend on maternal symptom improvement. In a first step focusing on treatment of maternal ADHD, 144 mothers of mother-child dyads were randomized to multimodal ADHD treatment (group psychotherapy plus methylphenidate) or clinical management (mainly supportive counselling). After 12 weeks (T2), a 12-week PCT program (T2-T3) for all mother-child dyads was added to treat children’s ADHD. Maternal symptomatology (CAARS-O:L; SCL-90-R) and children’s externalizing symptoms (ADHD-ODD Scale, SDQ) were repeatedly assessed (T1 = baseline, T2, T3). Effects of changes in maternal symptomatology (T1-T2) on the change in children’s symptom scores (T1-T3) were analysed using a general linear model, controlling for baseline scores, study centre, and maternal treatment group. 125 mother-child dyads were analysed. Mothers showed significant improvements in ADHD symptoms and overall psychopathology [CAARS-O:L ADHD index: mean – 3.54, SE 0.74 p < 0.0001; SCL-90-R Global Severity (GS): mean – 11.03, SE 3.90, p = 0.0056]. Although children’s externalizing symptoms improved significantly (ADHD-ODD Scale: mean – 4.46, SE 0.58, p < 0.0001), maternal improvement had no effect on children’s outcomes after Bonferroni-Holm correction for multiple testing. The findings do not support our hypothesis that children’s outcomes following PCT for ADHD depend on maternal symptom improvements.Trial register CCT-ISRCTN73911400.
PMID: 29362929 [PubMed – as supplied by publisher]
via https://www.ncbi.nlm.nih.gov/pubmed/29362929?dopt=Abstract

